The chemical substance known as (-)-9-[1(S),2(R)-Bis(hydroxymethyl)cyclopropan-1-ylmethyl]guanine, with the CAS number 145512-85-2, is a modified guanine derivative. This compound features a unique cyclopropane ring structure that is substituted with hydroxymethyl groups, contributing to its distinct chemical properties. The stereochemistry indicated by the (S) and (R) designations suggests that the molecule has specific three-dimensional orientations, which can significantly influence its biological activity and interactions. As a guanine analog, it may exhibit potential as an antiviral or anticancer agent by interfering with nucleic acid synthesis or function. The presence of hydroxymethyl groups enhances its solubility and may affect its binding affinity to biological targets. Overall, this compound represents a class of nucleoside analogs that are of interest in medicinal chemistry for their potential therapeutic applications. Further studies would be necessary to fully elucidate its pharmacological properties and mechanisms of action.

(-)-9-[1(S),2(R)-Bis(hydroxymethyl)cyclopropan-1-ylmethyl]guanine

145512-85-2: The chemical substance known as (-)-9-[1(S),2(R)-Bis(hydroxymethyl)cyclopropan-1-ylmethyl]guanine, with the CAS number 145512-85-2, is a modified guanine derivative. This compound features a unique cyclopropane ring structure that is substituted with hydroxymethyl groups, contributing to its distinct chemical properties. The stereochemistry indicated by the (S) and (R) designations suggests that the molecule has specific three-dimensional orientations, which can significantly influence its biological activity and interactions. As a guanine analog, it may exhibit potential as an antiviral or anticancer agent by interfering with nucleic acid synthesis or function. The presence of hydroxymethyl groups enhances its solubility and may affect its binding affinity to biological targets. Overall, this compound represents a class of nucleoside analogs that are of interest in medicinal chemistry for their potential therapeutic applications. Further studies would be necessary to fully elucidate its pharmacological properties and mechanisms of action.

Eprociclovir

<p>Eprociclovir (A-5021) is a novel acyclovir analog that is a potent inhibitor of EHV1 replication and may be used for the treatment and/or prevention of</p>

CAS 145512-85-2

(-)-9-[1(S),2(R)-Bis(hydroxymethyl)cyclopropan-1-ylmethyl]guanine

Eprociclovir

Ref: 54-BUP02241

Eprociclovir

Ref: TM-T31659